AN OUTBREAK OF INFECTIONS CAUSED BY STRAINS OF STAPHYLOCOCCUS AUREUS RESISTANT TO METHICILLIN AND AMINOGLYCOSIDES. II: EPIDEMIOLOGIC STUDIESCROSSLEY K; LANDESMAN B; ZASKE D et al.1979; J. INFECT. DIS.; ISSN 0022-1899; USA; DA. 1979; VOL. 139; NO 3; PP. 280-287; BIBL. 20 REF.Article

PHENOBARBITAL DOSAGE FOR CONTROL OF NEONATAL SEIZURESLOCKMAN LA; KRIEL R; ZASKE D et al.1979; NEUROLOGY; USA; DA. 1979; VOL. 29; NO 11; PP. 1445-1449; BIBL. 8 REF.Article

USING DISCRIMINANT FUNCTION ANALYSIS TO ESTIMATE THE IMPACT OF A THERAPEUTIC INTERVENTION IN BURN CASEBOOTMAN JL; WERTHEIMER AI; ZASKE D et al.1980; BURNS; GBR; DA. 1980; VOL. 6; NO 3; PP. 149-155; BIBL. 9 REF.Article

CEFACLOR PHARMACOKINETIC PARAMETERS: SERUM CONCENTRATIONS DETERMINED BY A NEW HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC TECHNIQUEROTSCHAFER JC; CROSSLEY KB; LESAR TS et al.1982; ANTIMICROB. AGENTS CHEMOTHER.; ISSN 0066-4804; USA; DA. 1982; VOL. 21; NO 1; PP. 170-172; BIBL. 19 REF.Article

COMPARATIVE STUDY OF CEFACLOR AND AMOXICILLIN IN TREATMENT OF URINARY TRACT INFECTIONROTSCHAFER J; CROSSLEY K; ZASKE D et al.1979; UROLOGY; USA; DA. 1979; VOL. 14; NO 3; PP. 233-236; BIBL. 12 REF.Article

INDIVIDUALIZING GENTAMICIN DOSAGE REGIMENS IN BURN PATIENTS WITH GRAM-NEGATIVE SEPTICEMIA: A COST-BENEFIT ANALYSISBOOTMAN JL; WERTHEIMER AI; ZASKE D et al.1979; J. PHARM. SCI.; USA; DA. 1979; VOL. 68; NO 3; PP. 267-272; BIBL. 20 REF.Article

Protamine sulfate and fatal anaphylactoid shockSHIKUMA, L. R; EYER, S. D; ZASKE, D. E et al.Drug intelligence & clinical pharmacy. 1988, Vol 22, Num 3, pp 211-213, issn 0012-6578Article

Initial dosage regimens of gentamicin in patients with burnsZASKE, D. E; CHIN, T; KOHLS, P. R et al.The Journal of burn care & rehabilitation. 1991, Vol 12, Num 1, pp 46-50, issn 0273-8481Article

Individualizing amikacin regimens : accurate method to achieve therapeutic concentrationsZASKE, D. E; CIPOLLE, R. J; ROTSCHAFER, J. C et al.Therapeutic drug monitoring. 1991, Vol 13, Num 6, pp 502-506, issn 0163-4356Article

Comparison of pharmacokinetic and safety profiles of amantadine 50- and 100-mg daily doses in elderly nursing home residentsSOMANI, S. K; DEGELAU, J; COOPER, S. L et al.Pharmacotherapy. 1991, Vol 11, Num 6, pp 460-466, issn 0277-0008Conference Paper

A retrospective study of sodium nitroprusside use and assessment of the potential risk of cyanide poisoningJOHANNING, R. J; ZASKE, D. E; TSCHIDA, S. J et al.Pharmacotherapy. 1995, Vol 15, Num 6, pp 773-777, issn 0277-0008Article

Physiologic response of stress and aminoglycoside clearance in critically ill patientsTHOLL, D. A; SHIKUMA, L. R; MILLER, T. Q et al.Critical care medicine. 1993, Vol 21, Num 2, pp 248-251, issn 0090-3493Article

Thermal injury effects on drug disposition : a prospective study with piperacillinSHIKUMA, L. R; ACKERMAN, B. H; WEAVER, R. H et al.Journal of clinical pharmacology. 1990, Vol 30, Num 7, pp 632-637, issn 0091-2700, 6 p.Article

Effects of treatment and the metabolic response to injury on drug clearance: a prospective study with piperacillinSHIKUMA, L. R; ACKERMAN, B. H; WEAVER, R. H et al.Critical care medicine. 1990, Vol 18, Num 1, pp 37-41, issn 0090-3493, 5 p.Article